Selected article for: "activity type and acute myeloid leukemia"

Author: Homma, Takujiro; Ishibashi, Daisuke; Nakagaki, Takehiro; Fuse, Takayuki; Sano, Kazunori; Satoh, Katsuya; Atarashi, Ryuichiro; Nishida, Noriyuki
Title: Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3
  • Document date: 2014_8_8
  • ID: jspxlk1a_7
    Snippet: Oct-1 is responsible for IRF-3 promoter activity. We identified putative transcription factor binding sites in nt -119 to -1 with the software TFSEARCH ver.1.3 (http://www.cbrc.jp/research/db/ TFSEARCH.html) and found that this region contains a potential Oct-1 binding site (59-ATTTGCAT-39, nt -42 to -35) and an acute myeloid leukemia 1 protein (AML1) binding site (59-TGCGGT-39, nt -49 to -44). In addition, an E2F transcription factor 1 (E2F1) bi.....
    Document: Oct-1 is responsible for IRF-3 promoter activity. We identified putative transcription factor binding sites in nt -119 to -1 with the software TFSEARCH ver.1.3 (http://www.cbrc.jp/research/db/ TFSEARCH.html) and found that this region contains a potential Oct-1 binding site (59-ATTTGCAT-39, nt -42 to -35) and an acute myeloid leukemia 1 protein (AML1) binding site (59-TGCGGT-39, nt -49 to -44). In addition, an E2F transcription factor 1 (E2F1) binding site (59-TTTCCCAC-39, nt -116 to -109) was also conserved in murine (Fig. 3a) . To determine whether the Oct-1 site is important for promoter activity, an original and two different mutated plasmids from the Oct-1 site (M1 and M2) were prepared (Fig. 3b ) and the transiently transfected into N2a and 3T3 cells. After 24 h, we evaluated their respective promoter activity by reporter assay. The activities of pGL3 -119/-1 (M1) were also significantly reduced compared with the original promoter activities in N2a and 3T3 cells ( Fig. 3c and 3d ). The activities of pGL3 -1000/-1 (M1) and pGL3 -523/-1 (M1) were also significantly reduced ( Supplementary Fig. S3 ). We obtained similar results in the second mutated plasmid pGL3 -119/-1 (M2) where activity was also significantly reduced in N2a and 3T3 cells ( Fig. 3e and 3f) . These results indicate that the Oct-1 site might play a crucial role for murine IRF-3 promoter activity. We next determined whether the E2F1 site was important for the promoter activity. The original plasmid pGL3 -119/-1 and the E2F1 site mutated plasmid (M3: Fig. 3g ) were transiently transfected into N2a and 3T3 cells. After 24 h, we evaluated their respective promoter activity by reporter assay. The activities of pGL3 -119/-1 (M3) were not significantly different compared to the original plasmid promoter activity in N2a and 3T3 cells ( Fig. 3h and 3i) , indicating the E2F1 is not an important determining factor for the regulation of murine IRF-3 promoter. Since two different mutations in the AML1 site (M4 and M5: shown in Supplementary Fig. S4a ) had little effect on the promoter activity in N2a58 cells (N2a cells overexpress wild-type prion protein), indicating the AML1 is not also important ( Supplementary Fig. S4b ).

    Search related documents:
    Co phrase search for related documents
    • AML1 site and murine promoter activity: 1
    • AML1 site and promoter activity: 1
    • AML1 site and transcription factor: 1
    • crucial role and determine factor: 1
    • crucial role and different mutation: 1
    • crucial role and little effect: 1, 2, 3
    • crucial role and murine promoter: 1
    • crucial role and murine promoter activity: 1
    • crucial role and prion protein: 1
    • crucial role and promoter activity: 1, 2, 3, 4, 5
    • crucial role and significantly reduce: 1, 2, 3, 4, 5
    • crucial role and similar result: 1
    • crucial role and transcription factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • crucial role and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34